アイアン・レイダー: 骨髄 の 腫瘍
Jiashuo Zheng1, Marcus Conrad2
1Helmholtz Zentrum München, Institute of Metabolism and Cell Death, Molecular Targets and Therapeutics Center, 85764 Neuherberg, Germany.
Cell
|October 31, 2025
まとめ
骨髄の腫瘍細胞は 赤血球から鉄を盗むために マクロファージを乗っ取ります この鉄の盗難は癌の成長を促し 貧血を引き起こします
科学分野:
- 腫瘍学
- 血液学
- 細胞生物学
背景:
- 転移は癌細胞が 遠くの臓器に広がる複雑なプロセスです
- 骨髄は転移の一般的な場所であり,血液細胞の産生に影響します.
- マクロファージは免疫細胞で,鉄の恒常化と組織修復に関与する.
研究 の 目的:
- 転移する腫瘍細胞と骨髄マクロファージの間の代謝相互作用を調査する.
- 腫瘍細胞が骨髄転移時に必要な栄養素を取得するメカニズムを解明する.
- これらの相互作用が腫瘍の進行と宿主貧血に与える影響を理解する.
主な方法:
- 骨髄転移のマウスモデルを使用した.
- 細胞間相互作用を特定するために,系統追跡と単細胞RNA配列を解析した.
- メタボリックラベリングと鉄定量測定を行った.
- 赤血球の整体性とマクロファージの鉄分を分析した
主要な成果:
- 転移した腫瘍細胞が 骨髄のマクロファージを再プログラムする
- 腫瘍細胞がマクロファージを誘導して 赤血球を溶かすことを示した.
- マクロファージによって赤血球から放出される鉄を効率的に抽出することが示されました.
- 腫瘍細胞の増殖と宿主における貧血の誘導と相関する.
結論:
- 転移した腫瘍細胞は 骨髄内のマクロファージを利用して 鉄を吸収します
- この代謝再プログラムが 腫瘍の成長を促し 癌に関連した貧血を引き起こします
- この腫瘍-マクロファージの代謝軸をターゲットにすることで,転移した癌の治療戦略を提供することができる.
関連する概念動画
Bone Marrow Sampling and Transplants
858
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
858
Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
The Periodic Table and Organismal Elements
199.4K
Overview
199.4K
Factors Affecting Erythropoiesis
5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K
Overview of Hematopoiesis
8.2K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.2K


